Global Prescription Dermatology Therapeutics Market Size, Status and Forecast 2020-2026

May 2020 | 98 pages | ID: G8B3202E5124EN
QYResearch

Abstracts

This report focuses on the global Prescription Dermatology Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prescription Dermatology Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Pfizer
• AbbVie
• Johnson & Johnson
• Novartis
• Amgen
• Eli Lilly
• Celgene
• LEO Pharma
• Bausch Health Companies
• Sun Pharmaceutical
• Aclaris Therapeutics

Market segment by Type, the product can be split into

• Fungal Infection Drugs
• Skin Cancer Drugs
• Acne & Rosacea Drugs
• Psoriasis Drugs
• Dermatitis & Seborrhea Drugs

Market segment by Application, split into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Prescription Dermatology Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Prescription Dermatology Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Prescription Dermatology Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Prescription Dermatology Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Prescription Dermatology Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Fungal Infection Drugs
  1.4.3 Skin Cancer Drugs
  1.4.4 Acne & Rosacea Drugs
  1.4.5 Psoriasis Drugs
  1.4.6 Dermatitis & Seborrhea Drugs
1.5 Market by Application
  1.5.1 Global Prescription Dermatology Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacies
  1.5.3 Retail Pharmacies
  1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Prescription Dermatology Therapeutics Market Perspective (2015-2026)
2.2 Prescription Dermatology Therapeutics Growth Trends by Regions
  2.2.1 Prescription Dermatology Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Prescription Dermatology Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Prescription Dermatology Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Prescription Dermatology Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Prescription Dermatology Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Prescription Dermatology Therapeutics Players by Market Size
  3.1.1 Global Top Prescription Dermatology Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Prescription Dermatology Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Prescription Dermatology Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Prescription Dermatology Therapeutics Market Concentration Ratio
  3.2.1 Global Prescription Dermatology Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Prescription Dermatology Therapeutics Revenue in 2019
3.3 Prescription Dermatology Therapeutics Key Players Head office and Area Served
3.4 Key Players Prescription Dermatology Therapeutics Product Solution and Service
3.5 Date of Enter into Prescription Dermatology Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Prescription Dermatology Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Prescription Dermatology Therapeutics Forecasted Market Size by Type (2021-2026)

5 PRESCRIPTION DERMATOLOGY THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Prescription Dermatology Therapeutics Market Size by Application (2015-2020)
5.2 Global Prescription Dermatology Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Prescription Dermatology Therapeutics Market Size (2015-2020)
6.2 Prescription Dermatology Therapeutics Key Players in North America (2019-2020)
6.3 North America Prescription Dermatology Therapeutics Market Size by Type (2015-2020)
6.4 North America Prescription Dermatology Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Prescription Dermatology Therapeutics Market Size (2015-2020)
7.2 Prescription Dermatology Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Prescription Dermatology Therapeutics Market Size by Type (2015-2020)
7.4 Europe Prescription Dermatology Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Prescription Dermatology Therapeutics Market Size (2015-2020)
8.2 Prescription Dermatology Therapeutics Key Players in China (2019-2020)
8.3 China Prescription Dermatology Therapeutics Market Size by Type (2015-2020)
8.4 China Prescription Dermatology Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Prescription Dermatology Therapeutics Market Size (2015-2020)
9.2 Prescription Dermatology Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Prescription Dermatology Therapeutics Market Size by Type (2015-2020)
9.4 Japan Prescription Dermatology Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Prescription Dermatology Therapeutics Market Size (2015-2020)
10.2 Prescription Dermatology Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Prescription Dermatology Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Prescription Dermatology Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Prescription Dermatology Therapeutics Market Size (2015-2020)
11.2 Prescription Dermatology Therapeutics Key Players in India (2019-2020)
11.3 India Prescription Dermatology Therapeutics Market Size by Type (2015-2020)
11.4 India Prescription Dermatology Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Prescription Dermatology Therapeutics Market Size (2015-2020)
12.2 Prescription Dermatology Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Prescription Dermatology Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Prescription Dermatology Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Prescription Dermatology Therapeutics Introduction
  13.1.4 Pfizer Revenue in Prescription Dermatology Therapeutics Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 AbbVie
  13.2.1 AbbVie Company Details
  13.2.2 AbbVie Business Overview and Its Total Revenue
  13.2.3 AbbVie Prescription Dermatology Therapeutics Introduction
  13.2.4 AbbVie Revenue in Prescription Dermatology Therapeutics Business (2015-2020)
  13.2.5 AbbVie Recent Development
13.3 Johnson & Johnson
  13.3.1 Johnson & Johnson Company Details
  13.3.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.3.3 Johnson & Johnson Prescription Dermatology Therapeutics Introduction
  13.3.4 Johnson & Johnson Revenue in Prescription Dermatology Therapeutics Business (2015-2020)
  13.3.5 Johnson & Johnson Recent Development
13.4 Novartis
  13.4.1 Novartis Company Details
  13.4.2 Novartis Business Overview and Its Total Revenue
  13.4.3 Novartis Prescription Dermatology Therapeutics Introduction
  13.4.4 Novartis Revenue in Prescription Dermatology Therapeutics Business (2015-2020)
  13.4.5 Novartis Recent Development
13.5 Amgen
  13.5.1 Amgen Company Details
  13.5.2 Amgen Business Overview and Its Total Revenue
  13.5.3 Amgen Prescription Dermatology Therapeutics Introduction
  13.5.4 Amgen Revenue in Prescription Dermatology Therapeutics Business (2015-2020)
  13.5.5 Amgen Recent Development
13.6 Eli Lilly
  13.6.1 Eli Lilly Company Details
  13.6.2 Eli Lilly Business Overview and Its Total Revenue
  13.6.3 Eli Lilly Prescription Dermatology Therapeutics Introduction
  13.6.4 Eli Lilly Revenue in Prescription Dermatology Therapeutics Business (2015-2020)
  13.6.5 Eli Lilly Recent Development
13.7 Celgene
  13.7.1 Celgene Company Details
  13.7.2 Celgene Business Overview and Its Total Revenue
  13.7.3 Celgene Prescription Dermatology Therapeutics Introduction
  13.7.4 Celgene Revenue in Prescription Dermatology Therapeutics Business (2015-2020)
  13.7.5 Celgene Recent Development
13.8 LEO Pharma
  13.8.1 LEO Pharma Company Details
  13.8.2 LEO Pharma Business Overview and Its Total Revenue
  13.8.3 LEO Pharma Prescription Dermatology Therapeutics Introduction
  13.8.4 LEO Pharma Revenue in Prescription Dermatology Therapeutics Business (2015-2020)
  13.8.5 LEO Pharma Recent Development
13.9 Bausch Health Companies
  13.9.1 Bausch Health Companies Company Details
  13.9.2 Bausch Health Companies Business Overview and Its Total Revenue
  13.9.3 Bausch Health Companies Prescription Dermatology Therapeutics Introduction
  13.9.4 Bausch Health Companies Revenue in Prescription Dermatology Therapeutics Business (2015-2020)
  13.9.5 Bausch Health Companies Recent Development
13.10 Sun Pharmaceutical
  13.10.1 Sun Pharmaceutical Company Details
  13.10.2 Sun Pharmaceutical Business Overview and Its Total Revenue
  13.10.3 Sun Pharmaceutical Prescription Dermatology Therapeutics Introduction
  13.10.4 Sun Pharmaceutical Revenue in Prescription Dermatology Therapeutics Business (2015-2020)
  13.10.5 Sun Pharmaceutical Recent Development
13.11 Aclaris Therapeutics
  10.11.1 Aclaris Therapeutics Company Details
  10.11.2 Aclaris Therapeutics Business Overview and Its Total Revenue
  10.11.3 Aclaris Therapeutics Prescription Dermatology Therapeutics Introduction
  10.11.4 Aclaris Therapeutics Revenue in Prescription Dermatology Therapeutics Business (2015-2020)
  10.11.5 Aclaris Therapeutics Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Prescription Dermatology Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Prescription Dermatology Therapeutics Revenue
Table 3. Ranking of Global Top Prescription Dermatology Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Prescription Dermatology Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Fungal Infection Drugs
Table 6. Key Players of Skin Cancer Drugs
Table 7. Key Players of Acne & Rosacea Drugs
Table 8. Key Players of Psoriasis Drugs
Table 9. Key Players of Dermatitis & Seborrhea Drugs
Table 10. Global Prescription Dermatology Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Prescription Dermatology Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Prescription Dermatology Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Prescription Dermatology Therapeutics Market Share by Regions (2015-2020)
Table 14. Global Prescription Dermatology Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Prescription Dermatology Therapeutics Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Prescription Dermatology Therapeutics Market Growth Strategy
Table 20. Main Points Interviewed from Key Prescription Dermatology Therapeutics Players
Table 21. Global Prescription Dermatology Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 22. Global Prescription Dermatology Therapeutics Market Share by Players (2015-2020)
Table 23. Global Top Prescription Dermatology Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prescription Dermatology Therapeutics as of 2019)
Table 24. Global Prescription Dermatology Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Prescription Dermatology Therapeutics Product Solution and Service
Table 27. Date of Enter into Prescription Dermatology Therapeutics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Prescription Dermatology Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 30. Global Prescription Dermatology Therapeutics Market Size Share by Type (2015-2020)
Table 31. Global Prescription Dermatology Therapeutics Revenue Market Share by Type (2021-2026)
Table 32. Global Prescription Dermatology Therapeutics Market Size Share by Application (2015-2020)
Table 33. Global Prescription Dermatology Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 34. Global Prescription Dermatology Therapeutics Market Size Share by Application (2021-2026)
Table 35. North America Key Players Prescription Dermatology Therapeutics Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Prescription Dermatology Therapeutics Market Share (2019-2020)
Table 37. North America Prescription Dermatology Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 38. North America Prescription Dermatology Therapeutics Market Share by Type (2015-2020)
Table 39. North America Prescription Dermatology Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 40. North America Prescription Dermatology Therapeutics Market Share by Application (2015-2020)
Table 41. Europe Key Players Prescription Dermatology Therapeutics Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Prescription Dermatology Therapeutics Market Share (2019-2020)
Table 43. Europe Prescription Dermatology Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Prescription Dermatology Therapeutics Market Share by Type (2015-2020)
Table 45. Europe Prescription Dermatology Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Prescription Dermatology Therapeutics Market Share by Application (2015-2020)
Table 47. China Key Players Prescription Dermatology Therapeutics Revenue (2019-2020) (Million US$)
Table 48. China Key Players Prescription Dermatology Therapeutics Market Share (2019-2020)
Table 49. China Prescription Dermatology Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 50. China Prescription Dermatology Therapeutics Market Share by Type (2015-2020)
Table 51. China Prescription Dermatology Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 52. China Prescription Dermatology Therapeutics Market Share by Application (2015-2020)
Table 53. Japan Key Players Prescription Dermatology Therapeutics Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Prescription Dermatology Therapeutics Market Share (2019-2020)
Table 55. Japan Prescription Dermatology Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Prescription Dermatology Therapeutics Market Share by Type (2015-2020)
Table 57. Japan Prescription Dermatology Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Prescription Dermatology Therapeutics Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Prescription Dermatology Therapeutics Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Prescription Dermatology Therapeutics Market Share (2019-2020)
Table 61. Southeast Asia Prescription Dermatology Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Prescription Dermatology Therapeutics Market Share by Type (2015-2020)
Table 63. Southeast Asia Prescription Dermatology Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Prescription Dermatology Therapeutics Market Share by Application (2015-2020)
Table 65. India Key Players Prescription Dermatology Therapeutics Revenue (2019-2020) (Million US$)
Table 66. India Key Players Prescription Dermatology Therapeutics Market Share (2019-2020)
Table 67. India Prescription Dermatology Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 68. India Prescription Dermatology Therapeutics Market Share by Type (2015-2020)
Table 69. India Prescription Dermatology Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 70. India Prescription Dermatology Therapeutics Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Prescription Dermatology Therapeutics Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Prescription Dermatology Therapeutics Market Share (2019-2020)
Table 73. Central & South America Prescription Dermatology Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Prescription Dermatology Therapeutics Market Share by Type (2015-2020)
Table 75. Central & South America Prescription Dermatology Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Prescription Dermatology Therapeutics Market Share by Application (2015-2020)
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Product
Table 80. Pfizer Revenue in Prescription Dermatology Therapeutics Business (2015-2020) (Million US$)
Table 81. Pfizer Recent Development
Table 82. AbbVie Company Details
Table 83. AbbVie Business Overview
Table 84. AbbVie Product
Table 85. AbbVie Revenue in Prescription Dermatology Therapeutics Business (2015-2020) (Million US$)
Table 86. AbbVie Recent Development
Table 87. Johnson & Johnson Company Details
Table 88. Johnson & Johnson Business Overview
Table 89. Johnson & Johnson Product
Table 90. Johnson & Johnson Revenue in Prescription Dermatology Therapeutics Business (2015-2020) (Million US$)
Table 91. Johnson & Johnson Recent Development
Table 92. Novartis Company Details
Table 93. Novartis Business Overview
Table 94. Novartis Product
Table 95. Novartis Revenue in Prescription Dermatology Therapeutics Business (2015-2020) (Million US$)
Table 96. Novartis Recent Development
Table 97. Amgen Company Details
Table 98. Amgen Business Overview
Table 99. Amgen Product
Table 100. Amgen Revenue in Prescription Dermatology Therapeutics Business (2015-2020) (Million US$)
Table 101. Amgen Recent Development
Table 102. Eli Lilly Company Details
Table 103. Eli Lilly Business Overview
Table 104. Eli Lilly Product
Table 105. Eli Lilly Revenue in Prescription Dermatology Therapeutics Business (2015-2020) (Million US$)
Table 106. Eli Lilly Recent Development
Table 107. Celgene Company Details
Table 108. Celgene Business Overview
Table 109. Celgene Product
Table 110. Celgene Revenue in Prescription Dermatology Therapeutics Business (2015-2020) (Million US$)
Table 111. Celgene Recent Development
Table 112. LEO Pharma Business Overview
Table 113. LEO Pharma Product
Table 114. LEO Pharma Company Details
Table 115. LEO Pharma Revenue in Prescription Dermatology Therapeutics Business (2015-2020) (Million US$)
Table 116. LEO Pharma Recent Development
Table 117. Bausch Health Companies Company Details
Table 118. Bausch Health Companies Business Overview
Table 119. Bausch Health Companies Product
Table 120. Bausch Health Companies Revenue in Prescription Dermatology Therapeutics Business (2015-2020) (Million US$)
Table 121. Bausch Health Companies Recent Development
Table 122. Sun Pharmaceutical Company Details
Table 123. Sun Pharmaceutical Business Overview
Table 124. Sun Pharmaceutical Product
Table 125. Sun Pharmaceutical Revenue in Prescription Dermatology Therapeutics Business (2015-2020) (Million US$)
Table 126. Sun Pharmaceutical Recent Development
Table 127. Aclaris Therapeutics Company Details
Table 128. Aclaris Therapeutics Business Overview
Table 129. Aclaris Therapeutics Product
Table 130. Aclaris Therapeutics Revenue in Prescription Dermatology Therapeutics Business (2015-2020) (Million US$)
Table 131. Aclaris Therapeutics Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Prescription Dermatology Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Fungal Infection Drugs Features
Figure 3. Skin Cancer Drugs Features
Figure 4. Acne & Rosacea Drugs Features
Figure 5. Psoriasis Drugs Features
Figure 6. Dermatitis & Seborrhea Drugs Features
Figure 7. Global Prescription Dermatology Therapeutics Market Share by Application: 2020 VS 2026
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Prescription Dermatology Therapeutics Report Years Considered
Figure 12. Global Prescription Dermatology Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Prescription Dermatology Therapeutics Market Share by Regions: 2020 VS 2026
Figure 14. Global Prescription Dermatology Therapeutics Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Prescription Dermatology Therapeutics Market Share by Players in 2019
Figure 17. Global Top Prescription Dermatology Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prescription Dermatology Therapeutics as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Prescription Dermatology Therapeutics Revenue in 2019
Figure 19. North America Prescription Dermatology Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Prescription Dermatology Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Prescription Dermatology Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Prescription Dermatology Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Prescription Dermatology Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Prescription Dermatology Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Prescription Dermatology Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Pfizer Revenue Growth Rate in Prescription Dermatology Therapeutics Business (2015-2020)
Figure 28. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. AbbVie Revenue Growth Rate in Prescription Dermatology Therapeutics Business (2015-2020)
Figure 30. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Johnson & Johnson Revenue Growth Rate in Prescription Dermatology Therapeutics Business (2015-2020)
Figure 32. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Novartis Revenue Growth Rate in Prescription Dermatology Therapeutics Business (2015-2020)
Figure 34. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Amgen Revenue Growth Rate in Prescription Dermatology Therapeutics Business (2015-2020)
Figure 36. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Eli Lilly Revenue Growth Rate in Prescription Dermatology Therapeutics Business (2015-2020)
Figure 38. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Celgene Revenue Growth Rate in Prescription Dermatology Therapeutics Business (2015-2020)
Figure 40. LEO Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. LEO Pharma Revenue Growth Rate in Prescription Dermatology Therapeutics Business (2015-2020)
Figure 42. Bausch Health Companies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Bausch Health Companies Revenue Growth Rate in Prescription Dermatology Therapeutics Business (2015-2020)
Figure 44. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Sun Pharmaceutical Revenue Growth Rate in Prescription Dermatology Therapeutics Business (2015-2020)
Figure 46. Aclaris Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Aclaris Therapeutics Revenue Growth Rate in Prescription Dermatology Therapeutics Business (2015-2020)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed